Arcay, Bb Girl .
HRN: 27-91-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/07/2025
AMPICILLIN 250MG (VIAL)
10/07/2025
10/13/2025
IV
75
Q12
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Final appropriateness: Yes
Overall appropriateness: Yes